IVAZZKA PHARMACUTICALS PRIVATE LIMITED
IVAZZKA PHARMACUTICALS PRIVATE LIMITED is a WEST BENGAL based PRIVATE LIMITED company, Registered at dated 29-JUL-2021 on Ministry of Corporate Affairs(MCA), The Corporate Identification Number (CIN) of IVAZZKA PHARMACUTICALS PRIVATE LIMITED is U24299WB2021PTC246824 and registration number is 246824.
It has been classified as COMPANY LIMITED BY SHARES and is registered under Registar of Companies KOLKATA India. Authorized share capital of IVAZZKA PHARMACUTICALS PRIVATE LIMITED is Rs. 1000000 and its paid up capital is Rs. 100000. It aspire to serve in MANUFACTURE OF CHEMICALS AND CHEMICAL PRODUCTS activities across the India.
Its Annual General Meeting (AGM) was lastly conducted on and as per the records of Ministry of Corporate Affairs (MCA), its balance sheet was last filed on .
IVAZZKA PHARMACUTICALS PRIVATE LIMITED has 2 directors NIRMALYA BISWAS, DEBASHRI DASGUPTA,
The registered Email address of IVAZZKA PHARMACUTICALS PRIVATE LIMITED is ivazzkappl@gmail.com and its registered address is PLOT NO 356/ 2118 PARULDANGA BIRBHUM BIRBHUM WB 731204 IN WEST BENGAL WEST BENGAL india 731204.
The current status of IVAZZKA PHARMACUTICALS PRIVATE LIMITED shows as ACTIVE
COMPANY BASIC DETAILS
IVAZZKA PHARMACUTICALS PRIVATE LIMITED
KOLKATA
ACTIVE
MANUFACTURE OF CHEMICALS AND CHEMICAL PRODUCTS
U24299WB2021PTC246824
29-JUL-2021
COMPANY LIMITED BY SHARES
NON-GOVT COMPANY
PRIVATE
1000000
100000
CONTACT DETAILS
731204
INDIA
PLOT NO 356/ 2118 PARULDANGA BIRBHUM BIRBHUM WB 731204 IN
ivazzkappl@gmail.com
DIRECTOR DETAILS
DIN | Director Name | Designation | Appointment Date |
---|---|---|---|
09260609 | NIRMALYA BISWAS | Director | 29/07/2021 |
09260610 | DEBASHRI DASGUPTA | Director | 29/07/2021 |
Details Updated by Companies
Quick Links
- All Registered company of WEST BENGAL
- Company Registered in WEST BENGAL
- All Registered company of BIRBHUM in WEST BENGAL
- Listed Company
- Company Category
- Latest Registered Company
Contact Us for Update Extra Information about your company and services.